Virtual drug design: Skp1–Skp2 inhibition targets cancer stem cells

Por Pascal, Laura E, Wang, Zhou
Publicado em 2013

Two paths for stabilization of ERG in prostate carcinogenesis: TMPRSS2-ERG fusions and speckle-type pox virus and zinc finger protein mutations

Por Pascal, Laura E, Wang, Zhou
Publicado no Asian J Androl (2016)

Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53

Por Su, Fei, Pascal, Laura E., Xiao, Wuhan, Wang, Zhou
Publicado em 2009

Improving intermittent androgen deprivation therapy: lessons learned from basic and translational research

Por Parikh, Rahul A, Pascal, Laura E, Davies, Benjamin J, Wang, Zhou
Publicado em 2014

Androgen receptor gene mutation, rearrangement, polymorphism

Por Eisermann, Kurtis, Wang, Dan, Jing, Yifeng, Pascal, Laura E., Wang, Zhou
Publicado em 2013

Growth of LAPC4 prostate cancer xenograft tumor is insensitive to 5α-reductase inhibitor dutasteride

Por Garcia, Raquel Ramos, Masoodi, Khalid Z, Pascal, Laura E, Nelson, Joel B, Wang, Zhou
Publicado no Am J Clin Exp Urol (2014)

The urologic epithelial stem cell database (UESC) – a web tool for cell type-specific gene expression and immunohistochemistry images of the prostate and bladder

Por Pascal, Laura E, Deutsch, Eric W, Campbell, David S, Korb, Martin, True, Lawrence D, Liu, Alvin Y
Publicado em 2007

Gene Expression Profiling Reveals Regulation of ERK Phosphorylation by Androgen-Induced Tumor Suppressor U19/EAF2 in the Mouse Prostate

Por Su, Fei, Correa, Bruna R. S., Luo, Jianhua, Vencio, Ricardo Z. N., Pascal, Laura E., Wang, Zhou
Publicado em 2013

ESTIMATING SHAPE CORRESPONDENCE FOR POPULATIONS OF OBJECTS WITH COMPLEX TOPOLOGY

Por Fishbaugh, James, Pascal, Laura, Fischer, Luke, Nguyen, Tung, Boen, Celso, Goncalves, Joao, Gerig, Guido, Paniagua, Beatriz
Publicado no Proc IEEE Int Symp Biomed Imaging (2018)

Hsp70 binds to the androgen receptor N-terminal domain and modulates the receptor function in prostate cancer cells

Por Dong, Jun, Wu, Zeyu, Wang, Dan, Pascal, Laura E., Nelson, Joel B., Wipf, Peter, Wang, Zhou
Publicado no Mol Cancer Ther (2018)

Anti-apoptotic factor Birc3 is up-regulated by ELL2 knockdown and stimulates proliferation in LNCaP cells

Por Wang, Zhi, Zhong, Mingming, Song, Qiong, Pascal, Laura E, Yang, Zhenyu, Wu, Zeyu, Wang, Ke, Wang, Zhou
Publicado no Am J Clin Exp Urol (2019)

EAF2 loss induces prostatic intraepithelial neoplasia from luminal epithelial cells in mice

Por Pascal, Laura E, Rigatti, Lora H, Ai, Junkui, Zhang, Aiyuan, Zhou, Jianhua, Nelson, Joel B, Wang, Zhou
Publicado no Am J Clin Exp Urol (2020)

EAF2 loss enhances angiogenic effects of Von Hippel-Lindau heterozygosity on the murine liver and prostate

Por Pascal, Laura E., Ai, Junkui, Rigatti, Lora H., Lipton, Anne K., Xiao, Wuhan, Gnarra, James R., Wang, Zhou
Publicado em 2011

AB012. E-cadherin is down-regulated in benign prostate hyperplasia and required for tight junction formation and permeability barrier in prostatic epithelial cell monolayer

Por Li, Feng, Pascal, Laura E., Parwani, Anil, Dhir, Rajiv, Nelson, Joel B., Guo, Peng, He, Dalin, Wang, Zhou
Publicado no Transl Androl Urol (2018)

ELL2 Is Required for the Growth and Survival of AR-Negative Prostate Cancer Cells

Por Wang, Zhi, Pascal, Laura E, Chandran, Uma R, Chaparala, Srilakshmi, Lv, Shidong, Ding, Hui, Qi, Lin, Wang, Zhou
Publicado no Cancer Manag Res (2020)

A novel androgen receptor antagonist JJ-450 inhibits enzalutamide-resistant mutant AR(F876L) nuclear import and function

Por Wu, Zeyu, Wang, Ke, Yang, Zhenyu, Pascal, Laura E., Nelson, Joel B., Takubo, Keita, Wipf, Peter, Wang, Zhou
Publicado no Prostate (2019)

Molecular and cellular characterization of ABCG2 in the prostate

Por Pascal, Laura E, Oudes, Asa J, Petersen, Timothy W, Goo, Young Ah, Walashek, Laura S, True, Lawrence D, Liu, Alvin Y
Publicado em 2007

Lineage relationship of prostate cancer cell types based on gene expression

Por Pascal, Laura E, Vêncio, Ricardo ZN, Vessella, Robert L, Ware, Carol B, Vêncio, Eneida F, Denyer, Gareth, Liu, Alvin Y
Publicado em 2011

The N-terminal domain of the androgen receptor drives its nuclear localization in castration-resistant prostate cancer cells

Por Dar, Javid A., Masoodi, Khalid Z., Eisermann, Kurtis, Isharwal, Sudhir, Ai, Junkui, Pascal, Laura E., Nelson, Joel B., Wang, Zhou
Publicado em 2014

5α-reductase Inhibition Coupled with Short Off Cycles Increases Survival in the LNCaP Xenograft Prostate Tumor Model on Intermittent Androgen Deprivation Therapy

Por Pascal, Laura E., Masoodi, Khalid Z., O’Malley, Katherine J., Shevrin, Daniel, Gingrich, Jeffrey R., Parikh, Rahul A., Wang, Zhou
Publicado no J Urol (2014)